USPTO serial 79447262
HEAL19
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- HUSSAIN, TASNEEM
- Law office
- TMO LAW OFFICE 118
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with HEAL19?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeanette E. Sinclare
Jeanette E. Sinclare Sheridan Ross P.C.1560 Broadway, Suite 1200Denver, CO 80202United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Bacteriological preparations other than for medical and veterinary use, namely, cultures of microorganisms other than for medical and veterinary use; milk ferments for industrial chemical purposes, namely, ferments for lactic acid; oils for preservation of food; bacteria and bacteria cultures for industrial use, in particular probiotic and bacteria and bacteria cultures being ingredients for use in the manufacture of dietary supplements and foodstuffs for human beings and animals | ACTIVE | — |
| 005 | Pharmaceutical, medical and veterinary products and preparations for use in treatment, supporting and promoting functions of the gastrointestinal tract, immune system, metabolic health, cardiovascular health, iron absorption and iron levels, bone and joint health, mental health, female health, healthy aging, human performance improvement, energy levels, sports performance, oral health, skin, hair and beauty benefits and dietary health and symptoms related thereto; nutritional food and drinks adapted for medical or veterinary use; probiotic food and drinks adapted for medical and veterinary use and healthcare; food for babies; infant and follow on formula for babies and toddlers; dietary supplements for humans and animals; bacterial and probiotic bacterial formulations and preparations and bacterial cultures for medical and veterinary use; cultures of microorganisms and preparations of microorganisms for medical and veterinary use; bacteriological culture mediums; probiotic supplements; nutritional supplements; nutraceuticals for use as a dietary supplement; probiotic bacteria and bacterial cultures for addition to food products as ingredients for use in the manufacture of dietetic foods and drinks adapted for pharmaceutical, medical, and veterinary purposes; bacteriological preparations and bacteriological preparations of microorganisms for use in the manufacture of dietetic preparations adapted for pharmaceutical, medical and veterinary use; food supplements and dietary supplemental drinks; probiotic supplement drinks for medical use; probiotic dietary supplemental drinks; protein dietary supplements in powder form; probiotic powders and preparations for medical use; dietary supplements, vitamin supplements, probiotic supplements, mineral supplements and nutritional supplements for animals and pets; medicated skin care preparations for medical use; medicated skin care preparations containing probiotic bacteria and bacterial cultures for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 31, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 31, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 31, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 11, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 11, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 25, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 25, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 14, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 13, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 6, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 2, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |